Public attitudes toward participation in cancer clinical trials.
暂无分享,去创建一个
Jon D. Miller | L. Krebs | Jon D Miller | R. Comis | Robert L Comis | Carolyn R Aldigé | Linda Krebs | Ellen Stoval | C. Aldigé | Ellen Stoval
[1] P. Butow,et al. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Gandara,et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Burnett Cb,et al. Factors that influence a patient's decision to participate in a phase I cancer clinical trial. , 2000 .
[4] J. Trauth,et al. Public Attitudes Regarding Willingness to Participate in Medical Research Studies , 2000, Journal of health & social policy.
[5] P M Ellis,et al. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] N Colabianchi,et al. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Kenneth N. Cissna,et al. Patients' Perceptions of Physicians Communication and Outcomes of the Accrual to Trial Process , 2000, Health communication.
[8] C. Coltman,et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.
[9] R. Prescott,et al. Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.
[10] C. Klabunde,et al. Factors influencing enrollment in clinical trials for cancer treatment. , 1999, Southern medical journal.
[11] M. Coovert,et al. Strategic physician communication and oncology clinical trials. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S. Vernon,et al. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial. , 1998, Preventive medicine.
[13] L. Yoder,et al. Expectations and experiences of patients with cancer participating in phase I clinical trials. , 1997, Oncology nursing forum.
[14] B. Rimer,et al. Participation in a women's breast cancer risk counseling trial: Who participates? Who declines? , 1996, Cancer.
[15] S L George,et al. Reducing patient eligibility criteria in cancer clinical trials. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] B. Rimer,et al. Recruiting high risk women into a breast cancer health promotion trial. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] Karl G. Jöreskog,et al. Lisrel 8: Structural Equation Modeling With the Simplis Command Language , 1993 .
[18] P. Engstrom,et al. Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] S. Piantadosi,et al. Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Ganz. Clinical trials. Concerns of the patient and the public , 1990 .
[21] L. Siminoff,et al. Doctor-patient communication about breast cancer adjuvant therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] C Loehlin John,et al. Latent variable models: an introduction to factor, path, and structural analysis , 1986 .
[23] C L Soskolne,et al. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. , 1984, The New England journal of medicine.
[24] D. J. Jackson,et al. Factor Analysis and Measurement in Sociological Research. , 1983 .
[25] E. Lusk,et al. Attitudes toward clinical trials among patients and the public. , 1982, JAMA.
[26] Linda G. Kimmel,et al. Biomedical communications : purposes, audiences, and strategies , 2001 .
[27] R. Prescott,et al. Factors that limit the quality, number and progress of randomised controlled trials. , 1999, Health technology assessment.
[28] Jon D. Miller,et al. Public perceptions of science and technology : a comparative study of the European Union, the United States, Japan, and Canada , 1997 .
[29] L. Siminoff,et al. Offering the option of randomized clinical trials to cancer patients who overestimate their prognoses with standard therapies. , 1993, Cancer investigation.
[30] C. Gotay,et al. Accrual to cancer clinical trials: directions from the research literature. , 1991, Social science & medicine.